Startups
Medinol
Edit

Medinol

http://www.medinol.com/
Last activity: 09.06.2025
Active
Categories: CultureDesignDrugFamilyLifeManufacturingProductScienceTechnologyWebsite
Medinol is dedicated to the science of cardiovascular intervention.

For over 25 years, we have delivered over two million coronary stents to patients worldwide. Our products constantly stretch the limits of innovation and our cutting-edge technology continues to demonstrate extraordinary clinical results. We make our products in-house using proprietary manufacturing technologies that ensure consistently exceptional quality and safety.

Medinol manufactures EluNIR™, the first elastomeric drug eluting stent. Now FDA approved and CE marked, EluNIR demonstrated excellent clinical outcomes and promising safety profile in two clinical studies and features the Flexx² catheter technology with a metallic spring-tip, resulting in unprecedented ease-of-delivery even in tough anatomies. A unique stent design provides low metal footprint and optimized vessel support, leveraged by an elastomeric coating that ensures excellent surface quality.

Founded in 1992 by Dr. Judith Richter and Dr. Kobi Richter and privately held to this day, Medinol continues to benefit from the leadership and insight of its founders. With more than 300 employees on board, we proudly maintain our family spirit and entrepreneurial culture.

Interested in joining Medinol ?
Click the link below to visit our website
Followers
108
Mentions
8

Overview

Location
Israel, Tel Aviv District, Tel Aviv-Yafo
Employees
201-500
Founded date
1992

Mentions in press and media 8

DateTitleDescription
Sign up to seeSign up to seeSign up to see
Jun 9, 2025Microtech Announces the First U.S. Atrial Microsensor Implantations as Part of its FIH StudyTEL AVIV, Israel, June 9, 2025 /PRNewswire/ -- Microtech, a wholly owned subsidiary of Medinol, is happy to announce the first U.S. implantations of its atrial-pressure microsensor. Two surgical implantations were performed on Friday, May 1...
Dec 26, 2024Microtech Announces First Human Case of Implantable Microsensor for Heart FailureTEL AVIV, Israel, Dec. 26, 2024 /PRNewswire/ -- Microtech, a wholly owned subsidiary of Medinol Inc., a leader in global MedTech research and development, announced that it has initiated human clinical trials of their microsensor platform, ...
Oct 7, 2024Medinol Announces Successful First-in-Human Implantation of ChampioNIR Drug-Eluting Peripheral Stent System in AustraliaTEL AVIV, Israel, Oct. 7, 2024 /PRNewswire/ -- Medinol Ltd. is pleased to announce the successful First-in-Human (FIH) implantation of the ChampioNIR Drug-Eluting Peripheral Stent by Drs Gerard S.Goh and Thodur Vasudevan of the Alfred Hospi...
Sep 13, 2022Microtech to unveil implantable microsensor technology at 34th Transcatheter Cardiovascular Therapeutics (TCT) annual meetingTEL AVIV, Israel, Sept. 13, 2022 /PRNewswire/ -- Microtech, a wholly owned subsidiary of Medinol, Inc., a leader in global MedTech research and development, announced that its implantable microsensor platform will be presented at the 34th T...
Nov 1, 2021Pharma startup Quris aims to use a ‘patient on a chip’ to target drug deliveryWe are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today! Nobel Laureate, Aaron Ciechanover, is one of seve...
Nov 1, 2021Pharma startup Quris aims to use a ‘patient on a chip’ to target drug deliveryNobel Laureate, Aaron Ciechanover, is one of several notable names behind pharma startup Quris. The company aims to bring together artificial intelligence, the industry’s vast knowledge of the human genome, and the concept of the “patient o...
Oct 22, 2012'It’s not rudeness, it’s chutzpah' – an insider’s take on Israel’s startup successWith the DLD Tel Aviv Conference kicking off tomorrow, part of a full week of festivities in one of the world’s most sizzling tech hubs, Israeli venture capitalist and tech journalist Gil Kerbs shares his take on the startup nation’s succes...

Reviews 0

Sign up to leave a review

Sign up Log In

FAQ about Medinol

When was Medinol founded?

Medinol was founded in 1992.

What has the press written about Medinol?

Parsers VC has collected 8 articles mentioning Medinol, among them “Microtech Announces the First U.S. Atrial Microsensor Implantations as Part of its FIH Study” (Jun 9, 2025) and “Microtech Announces First Human Case of Implantable Microsensor for Heart Failure” (Dec 26, 2024).

Is Medinol still active?

Yes, Medinol is active; its latest activity on Parsers VC dates from Jun 9, 2025.